Tumor necrosis factor-α (TNF-α) antagonists are effective against both Blau syndrome and Takayasu arteritis [36] and TNF-α is also a significant inflammatory factor in the NF-κB signaling pathway. The gene discussed is TNF; the disease is Takayasu arteritis.